Browsing: Medications

Agitation Anchor Art.jpg
Patient Interactions , Medications

Introducing the ‘Fiver’: A Modernized Alternative to the ‘B-52’ for Acute Agitation Control

7/22/2024 Matthew J. Christensen, MD, LT, MC, USN
Violence against health-care workers caused by acutely agitated patients is an unfortunate reality for many of us. When attempts at verbal redirection do not successfully de-escalate the situation, ex
Clonidine Anchor Art.jpg
Addiction Medicine , Toxicology , Medications

Case Report: A Review of Clonidine Overdose Management

3/19/2024 Rachel Martin, MD , Andrew Morgan, DO , Mark Gustafson, DO
Clonidine is a widely available drug and has been seen as the culprit in an increased number of intentional and accidental overdoses. Symptoms of toxicity include hypertension or hypotension, bradycar
47-5 Alpha-2 Agonist OD.jpeg
Toxicology , Medications

Strong Enough for a Giraffe, But Made for a Human: Alpha 2-adrenergic Agonist Overdose

10/9/2020 Scott H. Witt, MD , Erich Burton, DO
Recognizing alpha 2-agonist overdose and distinguishing it from other etiologies of bradycardia and hypotension is critically important.
47-5 Antidysrhythmic Toxicity.jpeg
Cardiology , Toxicology , Medications

Acute Hyperkalemia Masking Flecainide and Metoprolol Toxicity

10/9/2020 Matthew Baltz, MD , Jeremy Berberian, MD
Antidysrhythmic drugs are broadly categorized into Vaughan-Williams classifications, and their effects should be carefully noted.
46-6 GHB.jpg
Toxicology , Recreational Drugs , Medications

GHB: A Forgotten Foe Rises

12/16/2019 Garrett Prince, MD , Max Ofoma , Daniel O. Bral, DO, MPH
The classic story of GHB intoxication you may see in your ED — “you are about to intubate a comatose patient and they wake up suddenly.” What next?
45-5 VPA Overdose.jpg
Toxicology , Medications

Tackling Valproate Overdose

10/16/2018 John Mark Sawyer , Nicholas J. Connors, MD
Can you recognize severe valproate overdose? Understanding VPA pharmacokinetics is essential to help guide your treatment plan.
hpjc-1117.jpg
Health Policy Journal Club , Medications , Health Policy , Regulatory

Health Policy Journal Club: The Front Lines of the Opioid Epidemic

11/6/2017 Brandon Roe, DO
Health Policy Journal Club: The Front Lines of the Opioid Epidemic Mandating use of prescription drug monitoring programs cuts opioids by up to 10% Opioid prescriptions in the United States have been
drugs-180733212-1.jpg
Medications , Toxicology

Atrial Fibrillation after Naloxone Administration: A Rare Complication of Opioid Reversal

10/5/2017 Megan Gillespie, DO , Maricel Dela Cruz, DO, MPH , Jay Slutsky, DO
Atrial Fibrillation after Naloxone Administration: A Rare Complication of Opioid Reversal Background Naloxone is a widely used antidote critical in reversing the lethal effect of respiratory depressi
naxolene.png
Toxicology , Medications

Take-Home Naloxone: Preventing Death in an Era of Abuse

6/5/2017 Thomas del Ninno, MD , R. Gentry Wilkerson, MD, FACEPP , Danya Khoujah, MD
Take-Home Naloxone: Preventing Death in an Era of Abuse The United States is in the midst of an opioid epidemic, resulting in a significant increase in overdose deaths.1 From 2000 to 2014, there was
Bup.jpg
Toxicology , Medications

Bupropion: Skinny Happy Drug or Toxicologic Menace?

8/1/2016 Roxanne Thomas, MD , Joshua Shulman, MD , Anthony Pizon, MD
Bupropion: Skinny Happy Drug or Toxicologic Menace? A 24-year-old woman with a history of bulimia and depression is brought to the emergency department by ambulance. The patient is agitated and unab